NYSE:HCA - HCA Healthcare Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $177.71
  • Forecasted Upside: -7.83 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$192.80
▲ +4.22 (2.24%)
1 month | 3 months | 12 months
Get New HCA Healthcare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HCA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HCA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$177.71
▼ -7.83% Downside Potential
This price target is based on 16 analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $177.71, with a high forecast of $230.00 and a low forecast of $100.00. The average price target represents a -7.83% upside from the last price of $192.80.
Buy
The current consensus among 16 investment analysts is to buy stock in HCA Healthcare. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 14 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/21/2019
  • 0 strong buy ratings
  • 13 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/19/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/18/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/17/2020
  • 0 strong buy ratings
  • 18 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/15/2020
  • 0 strong buy ratings
  • 17 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/13/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/14/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/13/2021

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/14/2021Truist SecuritiesBoost Price TargetBuy$200.00 ➝ $230.00Medium
i
4/13/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$180.00 ➝ $210.00Medium
i
4/9/2021MizuhoBoost Price TargetBuy$195.00 ➝ $205.00Medium
i
2/5/2021MizuhoBoost Price TargetBuy$180.00 ➝ $195.00Medium
i
2/4/2021UBS GroupBoost Price TargetBuy$164.00 ➝ $203.00High
i
2/3/2021CitigroupBoost Price Target$185.00 ➝ $191.00Low
i
2/3/2021Credit Suisse GroupBoost Price TargetOutperform$197.00 ➝ $201.00High
i
2/3/2021Raymond JamesBoost Price TargetOutperform$150.00 ➝ $190.00High
i
1/5/2021TruistBoost Price Target$165.00 ➝ $190.00N/A
i
1/5/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$150.00 ➝ $180.00N/A
i
12/18/2020MizuhoBoost Price TargetBuy$170.00 ➝ $180.00Low
i
12/15/2020The Goldman Sachs GroupInitiated CoverageBuy$191.00Medium
i
12/14/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$143.00 ➝ $194.00High
i
12/7/2020MizuhoBoost Price TargetBuy$150.00 ➝ $170.00Medium
i
11/11/2020Piper SandlerBoost Price TargetOverweight$149.00 ➝ $163.00High
i
10/27/2020Smith Barney CitigroupBoost Price Target$142.00 ➝ $155.00Medium
i
10/27/2020Piper SandlerBoost Price TargetNeutral$138.00 ➝ $149.00High
i
10/27/2020Raymond JamesBoost Price TargetOutperform$140.00 ➝ $150.00High
i
10/27/2020Credit Suisse GroupBoost Price TargetOutperform$158.00 ➝ $164.00High
i
10/27/2020MizuhoBoost Price TargetBuy$145.00 ➝ $150.00High
i
10/27/2020BarclaysBoost Price TargetOverweight$140.00 ➝ $150.00High
i
10/9/2020CSFBBoost Price TargetOutperform$143.00 ➝ $158.00Medium
i
10/9/2020Credit Suisse GroupBoost Price TargetOutperform$143.00 ➝ $158.00High
i
9/21/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$161.00 ➝ $143.00High
i
9/16/2020TruistBoost Price TargetBuy$150.00 ➝ $165.00Low
i
7/24/2020JPMorgan Chase & Co.Boost Price TargetOverweight$142.00 ➝ $161.00Low
i
7/23/2020OppenheimerBoost Price Target$135.00 ➝ $140.00High
i
7/23/2020Deutsche Bank AktiengesellschaftBoost Price Target$132.00 ➝ $150.00Medium
i
7/23/2020Piper SandlerBoost Price TargetNeutral$132.00 ➝ $138.00Low
i
7/23/2020Raymond JamesBoost Price TargetCautious ➝ Outperform$130.00 ➝ $140.00High
i
7/23/2020SunTrust BanksBoost Price TargetBuy$130.00 ➝ $150.00High
i
7/23/2020MizuhoBoost Price TargetBuy$136.00 ➝ $145.00High
i
7/23/2020CitigroupBoost Price TargetBuy$131.00 ➝ $142.00High
i
7/13/2020BMO Capital MarketsDowngradeOutperform ➝ Market Perform$121.00 ➝ $100.00Low
i
6/11/2020UBS GroupLower Price TargetBuy$138.00 ➝ $137.00High
i
5/29/2020MizuhoLower Price TargetBuy$150.00 ➝ $136.00High
i
5/20/2020CitigroupLower Price TargetBuy$168.00 ➝ $131.00Medium
i
4/27/2020UBS GroupLower Price TargetBuy$183.00 ➝ $138.00Low
i
4/22/2020SunTrust BanksLower Price TargetBuy$160.00 ➝ $140.00Medium
i
4/22/2020BarclaysBoost Price TargetOverweight$117.00 ➝ $127.00Medium
i
4/22/2020Deutsche Bank AktiengesellschaftLower Price TargetBuy$165.00 ➝ $132.00Medium
i
4/22/2020OppenheimerLower Price TargetOutperform$160.00 ➝ $135.00Medium
i
4/20/2020Raymond JamesLower Price TargetOutperform$165.00 ➝ $130.00High
i
4/13/2020SunTrust BanksLower Price TargetBuy$185.00 ➝ $160.00High
i
3/25/2020BarclaysReiterated RatingBuy$117.00High
i
3/19/2020Credit Suisse GroupReiterated RatingBuy$173.00Low
i
2/3/2020BarclaysBoost Price TargetOverweight ➝ Positive$172.00 ➝ $177.00Low
i
1/29/2020SunTrust BanksReiterated RatingBuy$185.00Medium
i
1/29/2020Robert W. BairdBoost Price TargetOutperform$160.00 ➝ $180.00Low
i
1/29/2020Credit Suisse GroupBoost Price TargetOutperform$169.00 ➝ $173.00Low
i
1/29/2020StephensBoost Price TargetOverweight$175.00 ➝ $180.00Medium
i
Rating by Scott Fidel at Stephens
1/29/2020CitigroupBoost Price TargetBuy$156.00 ➝ $168.00Medium
i
1/29/2020Royal Bank of CanadaBoost Price TargetOutperform$170.00 ➝ $173.00Medium
i
1/27/2020The Goldman Sachs GroupReiterated RatingBuy$165.00High
i
Rating by Stephen Tanal at The Goldman Sachs Group, Inc.
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$157.00 ➝ $186.00Low
i
12/6/2019Bank of AmericaUpgradeNeutral ➝ BuyHigh
i
Rating by Kevin Fischbeck at Bank of America Co.
10/30/2019BarclaysBoost Price TargetOverweight$145.00 ➝ $155.00Low
i
9/6/2019Bank of AmericaUpgradeUnderperform ➝ Neutral$130.00 ➝ $137.00Medium
i
8/7/2019StephensSet Price TargetBuy$150.00Low
i
Rating by Scott Fidel at Stephens
7/31/2019MizuhoSet Price TargetBuy$153.00N/A
i
Rating by Ann Hynes at Mizuho
7/10/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$147.00 ➝ $160.00Low
i
6/24/2019UBS GroupBoost Price TargetBuy$172.00 ➝ $181.00Medium
i
5/1/2019UBS GroupBoost Price TargetBuy ➝ Buy$164.00 ➝ $172.00Low
i
5/1/2019Deutsche Bank AktiengesellschaftBoost Price TargetBuy ➝ Buy$160.00 ➝ $165.00Medium
i
4/23/2019Raymond JamesUpgradeMarket Perform ➝ Outperform$115.00 ➝ $135.00High
i
4/17/2019Jefferies Financial GroupSet Price TargetBuy$158.00High
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$155.00 ➝ $145.00Low
i
1/30/2019OppenheimerBoost Price TargetOutperform$142.00 ➝ $150.00Low
i
1/30/2019SunTrust BanksBoost Price TargetBuy$175.00Low
i
1/30/2019SVB LeerinkBoost Price TargetOutperform$160.00 ➝ $175.00Low
i
1/14/2019StephensInitiated CoverageOverweight$143.00Low
i
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
i
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$162.00Medium
i
11/6/2018ArgusBoost Price TargetBuy ➝ Buy$150.00 ➝ $155.00Low
i
11/1/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$156.00 ➝ $165.00Low
i
10/31/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$155.00 ➝ $158.00Low
i
10/11/2018CitigroupBoost Price TargetBuy$136.00 ➝ $156.00Medium
i
9/21/2018Jefferies Financial GroupBoost Price TargetBuy$155.00Low
i
9/20/2018Robert W. BairdBoost Price TargetOutperform ➝ Positive$130.00 ➝ $150.00Low
i
9/18/2018Bank of AmericaBoost Price TargetUnderperform$125.00 ➝ $135.00Medium
i
9/10/2018Royal Bank of CanadaBoost Price TargetOutperform$150.00Low
i
9/7/2018ArgusBoost Price TargetBuy$150.00Low
i
9/5/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$115.00 ➝ $124.00Low
i
9/5/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Buy$145.00 ➝ $155.00Low
i
9/4/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$150.00High
i
9/4/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $150.00Low
i
9/4/2018MizuhoSet Price TargetBuy$150.00Low
i
Rating by Ann Hynes at Mizuho
8/16/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$105.00 ➝ $115.00Medium
i
8/14/2018BarclaysInitiated CoverageOverweight$150.00Low
i
8/2/2018MizuhoReiterated RatingBuy$145.00Low
i
Rating by Ann Hynes at Mizuho
7/30/2018JPMorgan Chase & Co.Boost Price TargetOverweight$151.00Low
i
7/27/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$122.00 ➝ $143.00Low
i
7/26/2018Piper Jaffray CompaniesReiterated RatingHold$124.00Low
i
7/26/2018Jefferies Financial GroupReiterated RatingBuy$135.00Medium
i
7/26/2018SunTrust BanksBoost Price TargetBuy$145.00High
i
7/26/2018SVB LeerinkBoost Price TargetOutperform$125.00 ➝ $140.00High
i
7/20/2018Cantor FitzgeraldReiterated RatingBuy$115.00Low
i
7/20/2018SunTrust BanksReiterated RatingBuy$125.00Low
i
7/13/2018Morgan StanleyBoost Price TargetUnderweight$91.00 ➝ $98.00Low
i
3/23/2018MizuhoInitiated CoverageBuy$115.00Medium
i
Rating by Sheryl Skolnick at Mizuho
2/12/2018ArgusBoost Price TargetPositive ➝ Buy$9.26 ➝ $114.00Low
i
Rating by Jasper Hellweg at Argus
2/1/2018Sanford C. BernsteinReiterated RatingMarket Perform$105.00 ➝ $116.00Low
i
2/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$96.00 ➝ $115.00Low
i
2/1/2018Morgan StanleyBoost Price TargetUnderweight ➝ Underweight$84.00 ➝ $91.00Low
i
1/31/2018Royal Bank of CanadaBoost Price TargetOutperform$117.00Low
i
1/31/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$115.00 ➝ $122.00Low
i
1/31/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $120.00Low
i
1/31/2018SunTrust BanksBoost Price TargetBuy ➝ Positive$120.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
1/30/2018Piper Jaffray CompaniesReiterated RatingHold$101.00Low
i
1/30/2018Cantor FitzgeraldReiterated RatingBuy$115.00High
i
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$116.00High
i
1/24/2018William BlairReiterated RatingHoldMedium
i
Rating by M. Larew at William Blair
1/12/2018Robert W. BairdSet Price TargetBuy$104.00Medium
i
Rating by Whit Mayo at Robert W. Baird
1/10/2018ArgusSet Price TargetBuy$97.00Low
i
1/4/2018Bank of AmericaDowngradeNeutral ➝ Underperform$94.00 ➝ $90.00Medium
i
1/3/2018The Goldman Sachs GroupInitiated CoverageNeutral ➝ NeutralHigh
i
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$81.00High
i
12/26/2017Credit Suisse GroupReiterated RatingOutperform$25.00Low
i
12/21/2017SunTrust BanksSet Price TargetBuy$105.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/20/2017Morgan StanleyDowngradeEqual Weight ➝ Underweight$85.00High
i
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
i
11/30/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightHigh
i
11/21/2017William BlairReiterated RatingMarket PerformN/A
i
Rating by M. Larew at William Blair
11/6/2017CitigroupLower Price TargetNeutral ➝ Neutral$87.00 ➝ $81.00N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$95.00N/A
i
11/1/2017Jefferies Financial GroupLower Price TargetBuy$90.00 ➝ $88.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
11/1/2017MizuhoLower Price TargetBuy$85.00 ➝ $84.00N/A
i
Rating by Sheryl Skolnick at Mizuho
11/1/2017Piper Jaffray CompaniesReiterated RatingBuy$82.00N/A
i
10/31/2017Cantor FitzgeraldReiterated RatingBuy$90.00N/A
i
10/20/2017MizuhoReiterated RatingBuyN/A
i
Rating by Sheryl Skolnick at Mizuho
10/19/2017Robert W. BairdSet Price TargetBuy$93.00 ➝ $86.00N/A
i
10/19/2017OppenheimerReiterated RatingBuy$95.00 ➝ $90.00N/A
i
10/19/2017Bank of AmericaLower Price TargetNeutral$92.00 ➝ $86.00N/A
i
10/19/2017Royal Bank of CanadaReiterated RatingOutperform$90.00N/A
i
10/19/2017KeyCorpReiterated RatingOverweight$95.00 ➝ $90.00N/A
i
10/19/2017Jefferies Financial GroupReiterated RatingBuy$90.00N/A
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
10/18/2017Raymond JamesDowngradeStrong-Buy ➝ Market PerformN/A
i
10/18/2017UBS GroupDowngradeOutperform ➝ Market PerformN/A
i
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$90.00N/A
i
10/15/2017SunTrust BanksSet Price TargetBuy$90.00N/A
i
10/13/2017Cantor FitzgeraldReiterated RatingBuy$95.00N/A
i
10/13/2017Jefferies Financial GroupReiterated RatingBuy$92.00N/A
i
10/4/2017MizuhoReiterated RatingBuy$92.00N/A
i
10/4/2017Piper Jaffray CompaniesReiterated RatingBuy$92.00High
i
9/28/2017Robert W. BairdReiterated RatingBuyLow
i
9/7/2017KeyCorpReiterated RatingBuy$95.00Low
i
9/6/2017Cantor FitzgeraldReiterated RatingBuy$95.00Low
i
8/22/2017Robert W. BairdLower Price TargetOutperform$95.00 ➝ $93.00Low
i
8/17/2017Morgan StanleyLower Price TargetEqual Weight$88.00 ➝ $85.00Low
i
8/14/2017ArgusLower Price TargetBuy$100.00 ➝ $93.00Low
i
7/26/2017CitigroupLower Price TargetNeutral$89.00 ➝ $87.00Medium
i
7/26/2017Morgan StanleyReiterated RatingEqual Weight$90.00 ➝ $88.00Low
i
7/26/2017Bank of AmericaDowngradeBuy ➝ Neutral$102.00 ➝ $92.00Medium
i
6/28/2017ArgusInitiated CoverageBuy ➝ Buy$100.00Low
i
6/6/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$92.00 ➝ $100.00Low
i
Rating by A. Gupte at SVB Leerink LLC
6/6/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$90.00Low
i
4/17/2017Cantor FitzgeraldReiterated RatingBuy$95.00High
i
4/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy$103.00Low
i
3/27/2017MizuhoUpgradeNeutral ➝ Buy$98.00High
i
2/1/2017Royal Bank of CanadaReiterated RatingOutperform$95.00 ➝ $98.00N/A
i
2/1/2017Royal Bank of CanadaBoost Price TargetOutperform$95.00 ➝ $98.00N/A
i
1/31/2017Evercore ISIBoost Price TargetBuy$88.00N/A
i
1/17/2017Avondale PartnersUpgradeMarket Perform ➝ Outperform$96.00N/A
i
Rating by P. Torch at Avondale Partners
1/4/2017Piper Jaffray CompaniesInitiated CoverageOverweight$81.00N/A
i
11/15/2016Sanford C. BernsteinReiterated RatingMarket Perform$89.00 ➝ $85.00N/A
i
11/9/2016Avondale PartnersDowngradeOutperform ➝ Market PerformN/A
i
Rating by P. Torch at Avondale Partners
11/9/2016MizuhoDowngradeBuy ➝ NeutralN/A
i
10/28/2016Royal Bank of CanadaReiterated RatingOutperform$88.00 ➝ $95.00N/A
i
10/28/2016Royal Bank of CanadaBoost Price TargetOutperform$88.00 ➝ $95.00N/A
i
Rating by Frank Morgan at Royal Bank of Canada
10/25/2016Wolfe ResearchInitiated CoverageOutperformN/A
i
10/13/2016KeyCorpUpgradeSector Weight ➝ Overweight$94.00N/A
i
9/22/2016Evercore ISIInitiated CoverageHold$89.00N/A
i
9/6/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
8/26/2016Jefferies Financial GroupReiterated RatingBuy$94.00N/A
i
8/10/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
7/29/2016Credit Suisse GroupReiterated RatingBuy$87.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
7/29/2016CitigroupLower Price TargetNeutral$86.00 ➝ $85.00N/A
i
7/29/2016MizuhoReiterated RatingBuy$102.00 ➝ $97.00N/A
i
Rating by Sheryl Skolnick at Mizuho
7/29/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$85.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
7/14/2016MizuhoReiterated RatingBuy$102.00N/A
i
Rating by Sheryl Skolnick at Mizuho
6/28/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/16/2016Sanford C. BernsteinInitiated CoverageMarket Perform$88.00N/A
i
6/1/2016Longbow ResearchDowngradeOutperform ➝ Market Perform$74.00N/A
i
6/1/2016SVB LeerinkDowngradeOutperform ➝ Mkt PerformN/A
i
6/1/2016BarclaysLower Price TargetOverweight$80.00 ➝ $79.00N/A
i
5/16/2016Sterne Agee CRTReiterated RatingBuyN/A
i
Rating by B. Wright at Sterne Agee CRT
5/16/2016Robert W. BairdReiterated RatingBuyN/A
i
5/5/2016Credit Suisse GroupReiterated RatingBuy$90.00N/A
i
Rating by Ralph Giacobbe at Credit Suisse Group AG
5/5/2016JPMorgan Chase & Co.Reiterated RatingBuy$85.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
5/5/2016Jefferies Financial GroupReiterated RatingBuy$94.00N/A
i
5/4/2016OppenheimerReiterated RatingBuyN/A
i
Rating by Michael Wiederhorn at Oppenheimer Holdings Inc.
5/4/2016Bank of AmericaReiterated RatingBuy$92.00N/A
i
Rating by Kevin Fischbeck at Bank of America Co.
5/4/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
5/4/2016WedbushReiterated RatingOutperform$88.00 ➝ $90.00N/A
i
Rating by Sarah James at Wedbush
5/4/2016Royal Bank of CanadaReiterated RatingOutperform$86.00 ➝ $89.00N/A
i
4/17/2016Avondale PartnersReiterated RatingBuyN/A
i
Rating by Paula Torch at Avondale Partners
4/15/2016Avondale PartnersBoost Price TargetMarket Outperform$85.00 ➝ $92.00N/A
i
(Data available from 4/14/2016 forward)
HCA Healthcare logo
HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Read More

Today's Range

Now: $192.80
$189.06
$193.40

50 Day Range

MA: $184.83
$172.03
$191.82

52 Week Range

Now: $192.80
$91.21
$194.01

Volume

4,384 shs

Average Volume

1,564,816 shs

Market Capitalization

$64.96 billion

P/E Ratio

19.49

Dividend Yield

1.01%

Beta

1.58

Frequently Asked Questions

What sell-side analysts currently cover shares of HCA Healthcare?

The following sell-side analysts have issued research reports on HCA Healthcare in the last year: Barclays PLC, BMO Capital Markets, Citigroup Inc., Credit Suisse Group AG, CSFB, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Mizuho, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Smith Barney Citigroup, SunTrust Banks, Inc., The Goldman Sachs Group, Inc., TheStreet, Truist, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for HCA.

What is the current price target for HCA Healthcare?

16 Wall Street analysts have set twelve-month price targets for HCA Healthcare in the last year. Their average twelve-month price target is $174.44, suggesting a possible downside of 7.5%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting HCA will reach $210.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $100.00 for HCA Healthcare in the next year.
View the latest price targets for HCA.

What is the current consensus analyst rating for HCA Healthcare?

HCA Healthcare currently has 1 hold rating and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HCA will outperform the market and that investors should add to their positions of HCA Healthcare.
View the latest ratings for HCA.

What other companies compete with HCA Healthcare?

How do I contact HCA Healthcare's investor relations team?

HCA Healthcare's physical mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company's listed phone number is 615-344-9551 and its investor relations email address is [email protected] The official website for HCA Healthcare is www.hcahealthcare.com.